Research on e-cigarettes led by Professor Peter Hajek and colleagues from the Health and Lifestyle Research Unit at Queen Mary’s Wolfson Institute is among the 20 most discussed papers in the world in 2019.
17 December 2019
The paper presented a randomised trial of e-cigarettes versus nicotine replacement therapy in smoking cessation, and concluded that e-cigarettes could be much more effective than the ‘gold standard’ nicotine substitute in helping UK smokers quit, doubling the one-year abstinence rate. Speaking at the time, Professor Hajek said: “This is the first trial to test the efficacy of modern e-cigarettes in helping smokers quit. Although a large number of smokers report that they have quit smoking successfully with the help of e-cigarettes, health professionals have been reluctant to recommend their use because of the lack of clear evidence from randomised control trials. This is now likely to change.”
Measurement of online research discussion by analysts Altmetric placed the paper at number 20 on the list of the 100 most-discussed research papers over the last 12 months. The analysis collates and awards a weighted score to mentions in mainstream media, policy documents, social networks, blogs and other academic and non-academic forums.
Welcoming confirmation that his team’s paper has had such an impact, Professor Hajek said: “It’s obviously pleasing to hear that the paper is being analysed and talked about and we hope that means it will influence policy and practice.”
Peter Hajek, Anna Phillips-Waller, Dunja Przulj, Francesca Pesola, Katie Myers Smith, Natalie Bisal, Jinshuo Li, Steve Parrott, Peter Sasieni, Lynne Dawkins, Louise Ross, Maciej Goniewicz, Qi Wu, Hayden James McRobbie. A randomised trial of e-cigarettes versus nicotine replacement therapy. N Engl J Med 2019; 380:629-637
New England Journal of Medicine. DOI:10.1056/NEJMoa1808779